FDA Approves First OTC CGM for Kids

The FDA just approved Dexcom’s Stelo Glucose Biosensor System — the first OTC continuous glucose monitor for kids two and older not using insulin. Designed for use with adult supervision, it helps families track blood sugar every 15 minutes via a phone app, aiming to foster healthier habits as prediabetes rises in children. While safe and effective for most, it’s not for those on insulin, dialysis, or with low blood sugar risks — and always consult a doctor before use. Experts caution that glucose thresholds for healthy vs. unhealthy spikes still need more research. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/bbe401c397a52d9d